Prevention of New Metastatic Lesions by Eribulin Monotherapy Is Associated with Better Prognosis in Patients with Metastatic Breast Cancer.

Hara, Yukiko; Fukumoto, Satsuki; Mori, Satoshi; Goto, Hironori; Matsumoto, Kyoko; Enomoto, Katsuhisa; Tada, Keiichiro

Hara, Yukiko; Fukumoto, Satsuki; Mori, Satoshi; Goto, Hironori; Matsumoto, Kyoko; Enomoto, Katsuhisa; Tada, Keiichiro.

Afiliação

Hara Y; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.
Fukumoto S; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.
Mori S; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.
Goto H; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.
Matsumoto K; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.
Enomoto K; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.
Tada K; Department of Breast and Endocrine Surgery, Nihon University School of Medicine.

J Nippon Med Sch ; 89(5): 494-499, 2022 Nov 09.

Article em En | MEDLINE | ID: mdl-35644551

Assuntos

Antineoplásicos; Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/tratamento farmacológico; Neoplasias da Mama/patologia; Resultado do Tratamento; Furanos/uso terapêutico; Cetonas/uso terapêutico; Prognóstico; Metástase Neoplásica; Antineoplásicos/uso terapêutico

Palavras-chave

eribulin; overall survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article